Ionolyte

DRUG2 trials

Sponsors

Fresenius Kabi

Conditions

Hypovolaemia Due to Acute Blood LossHypovolemia Due to Acute Blood Loss

Phase 4

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

CompletedNCT03278548

Fresenius KabiHypovolaemia Due to Acute Blood Loss

Start: 2017-09-28End: 2022-07-06Updated: 2024-01-31

Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients

CompletedNCT03338218

Fresenius KabiHypovolemia Due to Acute Blood Loss

Start: 2019-02-23End: 2022-06-25Updated: 2022-08-05

Related Papers

Safety and efficacy of 6% hydroxyethyl starch in patients undergoing major surgery: The randomised controlled PHOENICS trial.

2025-10-24

PragmaTic, prospEctive, randomized, controlled, double-blind, mulTi-centre, multinational study on the safety and efficacy of a 6% HydroxYethyl Starch (HES) solution versus an electrolyte solution in trauma patients: study protocol for the TETHYS study.

2022-06-029 citations

Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study.

2022-02-2212 citations